Pity Bill Ackman and his Pershing Square hedge fund.
He's been after Botox maker Allergan for months now. Sadly, he was outspent by Actavis, an American generics giant headquartered in Ireland to avoid US corporate taxes.
But don't feel too sad for Bill. Reuters has the hedgie pocketing a cool $2,300,000,000.00 for his six months effort to coral the Botox manufacturer.
Nice work if you can get it.